EMCURE · Health Care · 2026-08-21

Emcure Pharmaceuticals Ltd

6.1★ FairStrong +6.9Stage 2 · wk 36In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹1,863
-0.98% today
₹35,337 Cr · Large cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Visit company website →
P/E (TTM)
35.4
Forward 23.2
Earnings Growth (YoY)
+28.8%
Revenue +16.7%
ROE
+19.6%
Profit margin +10.0%
Dividend Yield
0.18%
P/B 6.6
vs 52W High
-7.3%
₹1,271.8 lo₹2,009.6 hi
7.3% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 36
1w13w26w
Week 36 — mature, watch for distribution
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
16.0%
200 DMA: ₹1,606.1 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.70x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
MA20 gently rising · +2.4% vs MA50 +5.0%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #28 of 84 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Ranks #23 of 58 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2024-07-10 → 2026-08-21
S? 43w
S2 13w
S2 37w
2024-07-102026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 43w → S4 2w → S1 7w → S2 13w → S3 7w → S2 37w current
Total tracked: 110 weeks across 6 stage runs.
1M
-0.3%
3M
+8.7%
6M
+26.7%
YTD
+30.5%
1Y
+34.3%
Scan Membership
Breakout Watch
Latest: 2025-12-08
2 appearances in last 60 days. First seen: 2025-07-14.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 36 · Vol —x
2026-08-20S2
Wk 36 · Vol —x
2026-08-19S2
Wk 36 · Vol —x
2026-08-18S2
Wk 35 · Vol —x
2026-08-17S2
Wk 35 · Vol —x
2026-08-14S2
Wk 35 · Vol —x
2026-08-13S2
Wk 35 · Vol —x
2026-08-12S2
Wk 35 · Vol —x
2026-08-11S2
Wk 34 · Vol —x
2026-08-10S2
Wk 34 · Vol —x
2026-08-07S2
Wk 34 · Vol —x
2026-08-06S2
Wk 34 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹1,864.6
200 DMA
₹1,606.1
52W High
₹2,009.6
52W Low
₹1,271.8
5D Low
₹1,863
Resistance levels (recent highs)
20d High
₹2,009.6
60d High
₹2,009.6
120d High
₹2,009.6
250d High
₹2,009.6
Next resistance
+7.9%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.